Needham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy

Go back to Needham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy

BTIG Trims PT on AtriCure (ATRC) to $19; Management 'Disconnect' Causes Concern

August 8, 2016 11:17 AM EDT

BTIG cut its price target on Buy-rated AtriCure (NASDAQ: ATRC) from $34 down to $19 after the company reported Q2 results late last week.

Analyst Sean Lavin commented, ATRC reported a relatively in-line but messy quarter with the core business coming in soft while increased focus on nContact... More

AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper Jaffray

August 5, 2016 8:27 AM EDT

Piper Jaffray analyst Brooks West cut his price target on AtriCure Inc. (NASDAQ: ATRC) to $17.00 (from $22.00) following Q2 results, but maintained an Overweight rating saying guidance reset could be a positive clearing event.

West commented, "AtriCure reported 2Q16 revenues of $39.7M (+21.5% cc) vs. consensus of... More

AtriCure (ATRC) Tops Q2 EPS by 4c

August 4, 2016 5:16 PM EDT

AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $39.84 million.

"We are pleased to report second quarter results which reflect many accomplishments we launched two new... More

Trading Radar for 8/4: Kellogg (K), MGM Resorts (MGM), Activision (ATVI), FireEye (FEYE), Weight Watchers (WTW) Report

August 3, 2016 2:51 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 264kContinuing Claims - no Street consensus

Earnings:

AAC Holdings (NYSE: AAC) - consensus EPS $0.23
AGCO Corp. (Nasdaq: AGCO) - consensus EPS $0.92
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.77
Acceleron Pharma (NYSE: XLRN) - consensus loss $0.50
Agios Pharma (Nasdaq:... More